Seasoned physician-scientist and strategic clinical leader with 20 years of experience across clinical development, medical affairs, and translational research. Demonstrated success in building and leading cross-functional teams, managing global clinical programs, and delivering impactful regulatory submissions across oncology, dermatology, and inflammation. Expertise spans from Phase I to Phase III clinical trials, KOL engagement, protocol development, medical monitoring, and scientific communications. Combines NIH-trained academic rigor with biotech and pharma execution excellence.